Monica E. Murie

FDA investigator

Appears on 11 documents from 2022 to 2025, mostly at sites in Missouri. Most often cites control of microbiological contamination (21 CFR 211.113).

11
Documents on file
3.3
Observations per 483
2022
First seen
2025
Most recent

What they cite most

From 36 observations

Activity by year

2022: 2, 2023: 4, 2024: 2, 2025: 3

Where

Missouri 6 · China 2 · Japan 2 · Minnesota 1

Is Monica E. Murie coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 Tokyo Chemical Industry Co., Ltd.May 16, 2025 · Fukaya, Japan
483 KINKANDO CO., LTD.May 9, 2025 · HONJO-SHI, Japan
483 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical FactoryMar 7, 2025 · Xinchang, China
483 Shanghai Chuangshi Medical Technology (Group) Co., Ltd.Sep 13, 2024 · Qingpu, China
483 Sentio BioSciences LLCFeb 6, 2024 · Maryland Heights, Missouri
483 Patheon Biologics LLCDec 8, 2023 · Saint Louis, Missouri
483 SpecGx LLCSep 18, 2023 · Webster Groves, Missouri

About this profile

What does Monica E. Murie inspect?

Monica E. Murie appears on 11 documents on file covering 11 sites, mostly in Missouri.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Monica E. Murie is dated May 16, 2025.